Endogenous modification of the chemoattractant CXCL5 alters receptor usage and enhances its activity toward neutrophils and monocytes

Mieke Metzemaekers(Rega Institute for Medical Research), Paul Proost(Rega Institute for Medical Research), Anneleen Mortier(KU Leuven), Floriana Maria Farina(Humanitas University), Massimo Locati(University of Milan), Daiane Boff(Universidade Federal de Minas Gerais), Mauro Martins Teixeira(Universidade Federal de Minas Gerais), Samantha Milanesi(Ospedale Policlinico San Martino), Flávio A. Amaral(Universidade Federal de Minas Gerais), Elena Monica Borroni(University of Milan), Jo Van Damme(Cliniques Universitaires Saint-Luc), Noëmie Pörtner(Rega Institute for Medical Research), Marcello Allegretti(Dompé (Italy)), Alessandro Vacchini(Humanitas University), Karen Yu(Rega Institute for Medical Research), Rik Janssens(Universidade Federal de Minas Gerais), Nele Berghmans(Rega Institute for Medical Research)
Science Signaling
March 9, 2021
Cited by 33


Related Papers